Vaccine Design pp 175-180 | Cite as

The Immunological Co-Adjuvant Action of Liposomal Interleukin-15

  • Mayda Gursel
  • Gregory Gregoriadis
Part of the NATO ASI Series book series (NSSA, volume 293)


It is well known that the immunological adjuvant property of liposomes established in the early 70’s (Gregoriadis, 1990) can be further enhanced by interleukin-2 (IL-2) (Tan and Gregoriadis, 1989; Ho et al, 1992; Abraham and Shah, 1992; Sencer et al, 1991; Mbawuike et al, 1990; Anderson et al, 1994; Gursel and Gregoriadis, 1997a). It has been suggested (Meuer et al, 1989) that the co-adjuvant activity of liposomal IL-2 could prove useful in the vaccination of certain individuals who are low or non-responders (eg. immunosuppressed patients). Such findings with liposomal IL-2 have raised the question as to whether the recently discovered (Grabstein et al, 1994) interleukin-15 (IL-15) exhibits a similar action: IL-15 interacts with components of the IL-2 receptor and, as with IL-2, promotes T cell growth (Giri et al, 1994; Matthews et al, 1995; Carson et al, 1994), serves as a chemoattractant for human blood T-cells (Wilkinson and Liew, 1995) and induces B-cell proliferation and differentiation in the presence of stimuli (Armitage et al, 1995). Here we have studied IL-15 behaviour in vivo by entrapping the cytokine together with a model antigen (tetanus toxoid) into liposomes in a variety of formulations and monitoring its co-adjuvant activity in mice. Data indicate that IL-15 augments immune responses against the toxoid to levels well above those achieved with liposomal toxoid alone, but only when both the cytokine and the antigen are associated with the same vesicles.


Tetanus Toxoid Small Unilamellar Vesicle Covalent Coupling Liposomal Surface Empty Liposome 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Abraham, E. and Shah, S., 1992, Intranasal immunization with liposomes containing IL-2 enhances bacterial polysaccharide antigen-specific pulmonary secretory antibody responses, J.Immunol., 149: 3719.PubMedGoogle Scholar
  2. Anderson, P.M., Hanson, D.C., Hasz, M.R., Halet, Blazar, B.R. and Ochoa, A.C., 1994, Cytokines in liposomes: preliminary studies with IL-1, IL-2, IL-6, GM-CSF and interferon-γ, Cytokine, 6: 92.PubMedCrossRefGoogle Scholar
  3. Armitage, R.J., Macduff, B.M., Eisenman, J., Paxton, R. and Grabstein, K.H., 1995, IL-15 has stimulatory activity for the induction of B cell proliferation and differentiation, J. Immunol., 154: 483.PubMedGoogle Scholar
  4. Carson, W.E., Giri, J.G., Lindermann, M.J., Linett, ML., Ahdieh, M., Paxton, R., Anderson, D., Eisenmann, J., Grabstein, K. and Caliguri, M.A., 1994, Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor, J.Exp. Med., 180: 1395.PubMedCrossRefGoogle Scholar
  5. Garcon, N., Senior, J. and Gregoriadis, G., 1986, Coupling of ligands to liposomes before entrapment of agents sensitive to coupling procedures, Biochem.Soc.Trans., 14: 1038.Google Scholar
  6. Giri, J.G., Ahdieh, M., Eisenmann, J., Shanebeck, K., Grabstein, K., Kumaki, S., Name, A., Park, L.S., Cosman, D. and Anderson, D., 1994, Utilization of the β and γ chains of the IL-2 receptor by the novel cytokine IL-15, EMBO J., 13: 2822.PubMedGoogle Scholar
  7. Grabstein, K.H., Eisenmann, J., Shanebeck, K., Rauch, C., Srinivasan, S., Fung, V., Beers, C., Richardson, J., Schoenborn, M.A., Ahdieh, M., Johnson, L., Alderson, M.R., Watson, J.D., Anderson, D.M. and Giri, J.G., 1994, Cloning of a T cell growth factor that interacts with the β chain of the interleukin-2 receptor, Science, 264: 965.PubMedCrossRefGoogle Scholar
  8. Gregoriadis, G., 1990, Immunological adjuvants: A role for liposomes (Review) Immunol.Today, 11: 89.PubMedCrossRefGoogle Scholar
  9. Gregoriadis, G., Davis, D. and Davies, A., 1987, Liposomes as immunological adjuvants: Antigen incorporation studies, Vaccine, 5: 145.PubMedCrossRefGoogle Scholar
  10. Gregoriadis, G., Saffie, R. and de Souza, B., 1997, Liposome-mediated DNA vaccination, FEBS Lett, 402: 107.PubMedCrossRefGoogle Scholar
  11. Gregoriadis, G., Garcon, N., da Silva, H. and Sternberg, B., 1993, Coupling of ligands to liposomes independently of solute entrapment: Observations on the formed vesicles, Biochim.Biophys.Acta, 1147: 185.PubMedCrossRefGoogle Scholar
  12. Gursel, M. and Gregoriadis, G., 1997a, Interleukin-2 as a co-adjuvant for liposomal tetanus toxoid: The effect of cytokine and antigen mode of localization in the vesicles, J.Drug Targeting, in press.Google Scholar
  13. Gürsel, M. and Gregoriadis, G., 1997b, Interleukin-15 acts as an immunological co-adjuvant for liposomal antigen in vivo, Immunology Letters, 55: 161.PubMedCrossRefGoogle Scholar
  14. Heath, A.W. and Playfair, J.H.L., 1990, Conjugation of interferon-γ to antigen enhances its adjuvanticity, Immunology, 71: 454.PubMedGoogle Scholar
  15. Ho, R.J.Y., Burke, R.L. and Merigan, T.C., 1992, Liposome-formulated interleukin-2 as an adjuvant of recombinant HSV glycoprotein gD for the treatment of recurrent genital HSV-2 in guinea-pigs, Vaccine, 10: 209.PubMedCrossRefGoogle Scholar
  16. Kirby, C. and Gregoriadis, G., 1984, Dehydration-rehydration vesicles (DRV): A new method for high yield drug entrapment in liposomes, Biotechnology, 2: 979.CrossRefGoogle Scholar
  17. Kirby, C., Clarke, J. and Gregoriadis, G., 1980, Effect of the cholesterol content of small unilamellar liposomes on their stability in vivo and in vitro, Biochem.J., 186: 591.PubMedGoogle Scholar
  18. Matthews, D.J., Clark, P.A., Herbert, J., Morgan, G., Armitage, R.J., Kinnon, C., Minty, A., Grabstein, K.H., Caput, C., Ferrara, P. and Callard, R., 1995, Function of the interleukin-2 (IL-2) receptor γ-chain in biologic responses of X-linked severe combined immunodeficient B cells to IL-2, IL-4, IL-13 and IL-15, Blood, 85: 38.PubMedGoogle Scholar
  19. Mbawuike, I.N., Wyde, P.R. and Anderson, P.M., 1990, Enhancement of the protective efficacy of inactivated influenza A virus vaccine in aged mice by IL-2 liposomes, Vaccine, 8: 347.PubMedCrossRefGoogle Scholar
  20. McCormack, B. and Gregoriadis, G., 1994, Drugs-in-cyclodextrins-in liposomes: A novel concept in drug delivery, Int.J.Pharm., 112: 249.CrossRefGoogle Scholar
  21. Meuer, S.C., Dumann, H., Zum-Buschenfelde, K.H.M. and Kohler, H., 1989, Low-dose interleukin-2 induces systemic immune responses against HbsAg in immunodeficient non-responders to hepatitis B vaccination, The Lancet, 1: 15.CrossRefGoogle Scholar
  22. Roehm, N.W., Rodgers, G.H., Hatfield, S.M. and Glasebrook, A.L., 1991, An improved colorimetric assay for cell proliferation and viability utilizing the tetrazolium salt XTT, J.Immunol.Meth., 142: 257.CrossRefGoogle Scholar
  23. Sencer, S.F., Rich, M.L., Katsanis, E., Ochoa, A.C. and Anderson, P.M., 1991, Anti-tumor vaccine adjuvant effects of IL-2 liposomes in mice immunized against MCA-102 sarcoma, Eur.Cytokine Netw., 2: 311.PubMedGoogle Scholar
  24. Shahum, E. and Therien, H.-M., 1994, Correlation between in vitro and in vivo behaviour of liposomal antigens, Vaccine, 12: 1125.PubMedCrossRefGoogle Scholar
  25. Snyder, S.L. and Vannier, W.E., 1984, Immunologic response to protein immobilized on the surface of liposomes via covalent azo-bonding, Biochim.Biophys.Acta, 772: 288.PubMedCrossRefGoogle Scholar
  26. Tan, L. and Gregoriadis, G., 1989, Dehydration-rehydration vesicles (DRV): A new method for high yield drug entrapment in liposomes, Biochem.Soc.Trans., 17: 693.Google Scholar
  27. Wilkinson, P.C. and Liew, F.Y., 1995, Chemoattraction of human blood T lymphocytes by interleukin-15, J. Exp Med., 181: 1255.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1997

Authors and Affiliations

  • Mayda Gursel
    • 1
  • Gregory Gregoriadis
    • 1
  1. 1.Centre for Drug Delivery Research, The School of PharmacyUniversity of LondonLondonUK

Personalised recommendations